Unifocal, multifocal and diffuse carcinomas: A reproducibility study of breast cancer distribution, Breast, vol.22, pp.34-38, 2013. ,
Multifocality in "basal-like" breast carcinomas and its influence on lymph node status, Ann. Surg. Oncol, vol.18, pp.1671-1677, 2011. ,
Breast cancer multifocality and multicentricity and locoregional recurrence, Oncologist, vol.18, pp.1167-1173, 2013. ,
Evolving paradigms in multifocal breast cancer, Semin. Cancer Biol, vol.31, pp.111-118, 2015. ,
Derailed estrogen signaling and breast cancer: An authentic couple, Endocr. Rev, vol.34, pp.1-32, 2013. ,
Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer, Anticancer Res, vol.37, pp.4593-4598, 2017. ,
Effect of multifocality and multicentricity on outcome in early stage breast cancer: A systematic review and meta-analysis, Breast Cancer Res. Treat, vol.146, pp.235-244, 2014. ,
Clinical implications of multifocality as a prognostic factor in breast carcinoma-A multivariate analysis study comprising 460 cases, Int. J. Clin. Exp. Med, vol.8, pp.9839-9846, 2015. ,
Multicentric and multifocal versus unifocal breast cancer: Is the tumor-node-metastasis classification justified?, Breast Cancer Res. Treat, vol.122, pp.27-34, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00612984
Multicentric and multifocal versus unifocal breast cancer: Differences in the expression of E-cadherin suggest differences in tumor biology, BMC Cancer, vol.13, 2013. ,
Expression of estrogen receptor-beta in normal mammary and tumor tissues: Is it protective in breast carcinogenesis?, Breast Cancer Res. Treat, vol.80, pp.79-85, 2003. ,
The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development, J. Surg. Oncol, vol.93, pp.504-510, 2006. ,
Breast cancer prognosis predicted by nuclear receptor-coregulator networks, Mol. Oncol, vol.8, pp.998-1013, 2014. ,
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor, EMBO J, vol.14, pp.3741-3751, 1995. ,
Corepressors of agonist-bound nuclear receptors, Toxicol. Appl. Pharmacol, vol.223, pp.288-298, 2007. ,
The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypes, Clin. Cancer Res, vol.16, pp.2959-2970, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00482822
NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/?-catenin pathway, Oncotarget, vol.6, pp.25701-25714, 2015. ,
The emerging role of the transcriptional coregulator RIP140 in solid tumors, Biochim. Biophys. Acta, vol.1856, pp.144-150, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02316634
The nuclear receptor transcriptional coregulator RIP140, Nucl. Recept. Signal, 2006. ,
Negative regulation of estrogen signaling by ER? and RIP140 in ovarian cancer cells, Mol. Endocrinol, vol.27, pp.1429-1441, 2013. ,
Preferential estrogen receptor ? ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy, Mol. Cancer Ther, vol.13, pp.1882-1893, 2014. ,
Integrative genomics of gene and metabolic regulation by estrogen receptors ? and ?, and their coregulators, Mol. Syst. Biol, vol.9, 2013. ,
The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals, vol.140, pp.1079-1089, 2013. ,
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms, Mol. Cell, vol.11, pp.139-150, 2003. ,
Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice, J. Hepatol, vol.56, pp.248-254, 2012. ,
Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase, J. Biol. Chem, vol.286, pp.37108-37117, 2011. ,
Complex regulation of LCoR signaling in breast cancer cells, vol.36, pp.4790-4801, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02294843
Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival, Transl. Oncol, vol.11, pp.1090-1096, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02292304
Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients, Clin. Cancer Res, vol.14, pp.5228-5235, 2008. ,
Nuclear and cytoplasmic expressions of ER?1 and ER?2 are predictive of response to therapy and alters prognosis in familial breast cancers, Breast Cancer Res. Treat, vol.126, pp.395-405, 2011. ,
Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer, Am J. Transl. Res, vol.7, pp.1246-1259, 2015. ,
Estrogen receptor subtypes dictate the proliferative nature of the mammary gland, J. Endocrinol, vol.237, pp.323-336, 2018. ,
Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy, J Breast Cancer, vol.15, pp.79-86, 2012. ,
Expression and prognostic value of estrogen receptor beta in breast cancer patients, Int. J. Clin. Exp. Med, vol.7, pp.3730-3736, 2014. ,
Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis, Oncotarget, vol.7, pp.10373-10385, 2016. ,
Method for grading breast cancer, J. Clin. Pathol, vol.46, pp.189-190, 1993. ,
Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone, Anticancer Res, vol.25, pp.1719-1723, 2005. ,
Strong correlation between N-cadherin and CD133 in breast cancer: Role of both markers in metastatic events, J. Cancer Res. Clin. Oncol, vol.140, pp.1873-1881, 2014. ,